GB0405034D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0405034D0
GB0405034D0 GBGB0405034.0A GB0405034A GB0405034D0 GB 0405034 D0 GB0405034 D0 GB 0405034D0 GB 0405034 A GB0405034 A GB 0405034A GB 0405034 D0 GB0405034 D0 GB 0405034D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0405034.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0405034.0A priority Critical patent/GB0405034D0/en
Publication of GB0405034D0 publication Critical patent/GB0405034D0/en
Priority to PCT/EP2005/002305 priority patent/WO2005094797A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
GBGB0405034.0A 2004-03-05 2004-03-05 Organic compounds Ceased GB0405034D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0405034.0A GB0405034D0 (en) 2004-03-05 2004-03-05 Organic compounds
PCT/EP2005/002305 WO2005094797A2 (en) 2004-03-05 2005-03-04 Use of ampa-receptor antagonists for treating dementia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0405034.0A GB0405034D0 (en) 2004-03-05 2004-03-05 Organic compounds

Publications (1)

Publication Number Publication Date
GB0405034D0 true GB0405034D0 (en) 2004-04-07

Family

ID=32088811

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0405034.0A Ceased GB0405034D0 (en) 2004-03-05 2004-03-05 Organic compounds

Country Status (2)

Country Link
GB (1) GB0405034D0 (en)
WO (1) WO2005094797A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023042888A1 (en) * 2021-09-15 2023-03-23 国立大学法人 琉球大学 Pharmaceutical composition for treating cognitive decline or for treating overweightness or obesity

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4428835A1 (en) * 1994-08-01 1996-02-08 Schering Ag New 3-substituted 3H-2,3-benzodiazepine derivatives, their production and use as medicines
HU223945B1 (en) * 1994-09-27 2005-03-29 Yamanouchi Pharmaceutical Co., Ltd. 1,2,3,4-tetrahydroquinoxalindione derivatives and pharmaceutical compositions containing them
WO1998017672A1 (en) * 1996-10-24 1998-04-30 Novartis Ag Substituted aminoalkane phosphonic acids
US6060479A (en) * 1997-06-09 2000-05-09 Pfizer Inc Quinazoline-4-one AMPA antagonists
HUP9802585A3 (en) * 1998-11-09 2000-09-28 Gyogyszerkutato Intezet Pyridazinooxazepine, -thiazepine, -diazepine and thiazine derivatives and pharmaceutical compositions containing them
EP1423127A1 (en) * 2001-08-30 2004-06-02 Ortho-Mcneil Pharmaceutical, Inc. Treatment of dementia and memory disorders with anticonvulsants and acetylcholinesterase inhibitors
TW200403066A (en) * 2002-04-30 2004-03-01 Novartis Ag New uses of substituted aminoalkanephosphonic acids

Also Published As

Publication number Publication date
WO2005094797A2 (en) 2005-10-13
WO2005094797A3 (en) 2005-12-01

Similar Documents

Publication Publication Date Title
GB0410712D0 (en) Organic compounds
GB0409921D0 (en) Organic compounds
GB0403038D0 (en) Organic compounds
GB0407723D0 (en) Organic compounds
GB0401334D0 (en) Organic compounds
GB0402797D0 (en) Organic compounds
GB0405289D0 (en) Organic compounds
GB0404434D0 (en) Organic compounds
GB0408078D0 (en) Organic compounds
GB0400781D0 (en) Organic compounds
GB0406515D0 (en) Organic compounds
GB0403115D0 (en) Organic compounds
GB0403254D0 (en) Organic compounds
GB0405723D0 (en) Organic compounds
GB0409236D0 (en) Organic compounds
GB0406240D0 (en) Organic compounds
GB0405898D0 (en) Organic compounds
GB0405034D0 (en) Organic compounds
GB0407468D0 (en) Organic compounds
GB0407607D0 (en) Organic compounds
GB0405900D0 (en) Organic compounds
GB0407466D0 (en) Organic compounds
GB0403964D0 (en) Organic compounds
GB0402682D0 (en) Organic compounds
GB0400177D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)